CN106581235A - Pharmaceutical composition for treatment of soft tissue injuries - Google Patents
Pharmaceutical composition for treatment of soft tissue injuries Download PDFInfo
- Publication number
- CN106581235A CN106581235A CN201611189326.9A CN201611189326A CN106581235A CN 106581235 A CN106581235 A CN 106581235A CN 201611189326 A CN201611189326 A CN 201611189326A CN 106581235 A CN106581235 A CN 106581235A
- Authority
- CN
- China
- Prior art keywords
- parts
- soft tissue
- pharmaceutical composition
- treatment
- safflower
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Belonging to the technical field of medicine, the invention discloses a pharmaceutical composition for treatment of soft tissue injuries. The pharmaceutical composition comprises the following components by weight: 16-20 parts of Chinese angelica, 16-20 parts of Ligusticum wallichii, 7-11 parts of panax notoginseng, 7-11 parts of safflower, 7-11 parts of peach kernel, 7-11 parts of eucommia, 7-11 parts of dried tangerine peel, 7-10 parts of radix aconiti preparata, and 7-10 parts of processed radix aconiti kusnezoffii. The pharmaceutical composition provided by the invention can reach quick swelling diminishing and pain relieving on various closed soft tissue injuries, and promote soft tissue's quick restoration of normal functions, has an effective rate up to 100% on acute sprain and contusion, muscle strain, and articular ligament strain, the cure rate is up to 100%, the course of treatment is short, usually swelling can be eliminated within 24 hours, and full-recovery can be achieved within one week. For chronic tenosynovitis and periarthritis of shoulder, the effective rate is up to 100%, and the cure rate is up 95% or more. With the characteristics of exact curative effect, small toxic and side effect and low cost, the pharmaceutical composition can greatly mitigate patients' financial burden and mental burden.
Description
Technical field
The present invention relates to technical field of pharmaceuticals, more particularly to a kind of pharmaceutical composition for treating soft tissue injury.
Background technology
Soft tissue injury, is the most common disease of a class orthopedics and traumatology, generally refers to soft tissue or skeletal muscle is subject to direct
Or indirect violence, or the big class wound syndrome that long-term chronic strain causes；There is microcirculation disorder, aseptic in tissue after being wound
Property inflammation, cause local swelling pain, activity is unfavorable, and the traditional Chinese medical science is also referred to as " injury of the tissues ".
Soft tissue injury is divided into open soft tissue injury and the big class of closed soft tissue injury two again, and wherein closed is soft
Tissue damage refers to that local skin or mucous membrane are complete, communicates with the external world without breach, damages accompanied by tissue internal haemorrhage, tissue fluid often
Ooze out, form local hematoma or hemostasis, it is typically due to be acted on by blunt forces, and muscle fiercely shrinks, and joint motion surmounts normally
Scope or strain etc. cause.The type of common closed soft tissue loss, includes：It is acute as（1）Dampen；（2）Muscle
Pull；（3）Articular ligament is pulled；It is chronic as（4）Bursal synovitis；（5）Tenosynovitis；（6）Scapulohumeral periarthritis etc..For closed soft tissue
Damage, it is desirable to process treatment in time, if malpractice, not only can extend the period for the treatment of, it is also possible to affect the normal function of body, give
Patient causes larger economy and emotional distress.
At present, for soft tissue injury, the especially treatment of soft group of damage of closed is general using oral and external used medicine
Mode, also including physical therapies such as some ice compresses.Common medicine such as Yunnan Baiyao（Including spray）, Radix Notoginseng powder, tiger
Bone cream etc..In addition, also have the patent report of many Chinese medicine compound prescriptions, such as Application No. 200810140945.8, patent name
For a kind of Chinese patent of the medicine for treating soft tissue injury.
Current therapeutic modality, generally there are problems with：Treatment time is long, especially for more serious soft tissue
Damage and chronic soft tissue injury, the course for the treatment of is treated not thoroughly often up to even 1 year half a year, leaves some sequelae,
Normal work and the life of patient are affected, and medical expense is high, with different degrees of toxic and side effect, than as the aforementioned specially
Profit application, up to 20 kinds of the component of the patent, its security leaves a question open, and curative effect needs further raising.For tenosynovitis and
The chronic soft tissue injuries such as scapulohumeral periarthritis, therapeutic effect is poor, and is very easy to recurrence.
The content of the invention
The present invention goal of the invention be：A kind of pharmaceutical composition for treating soft tissue injury is provided, with solution
State problem.
The technical solution used in the present invention is such：A kind of pharmaceutical composition for treating soft tissue injury, by under
State the component composition of weight portion：
Radix Angelicae Sinensis：16-20 parts, Ligusticum wallichii：16-20 parts, pseudo-ginseng：7-11 parts, safflower：7-11 parts, peach kernel：7-11 parts, the bark of eucommia：7-11
Part, dried orange peel：7-11 parts, aconiti preparata,radix：7-10 parts, wild aconite root：7-10 parts.
The present inventor filters out above-mentioned nine traditional Chinese medicines by many experiments, and using suitable ratio, mutually assists
Together, the muscles and bones arthralgia caused because of strain and wind-cold damp pathogen can be particularly useful for warming and activating meridian, dispelling wind and eliminating dampness, cold dispelling, its treatment
Effect is definite, and short treating period, toxic and side effect is little.
Wherein, Radix Angelicae Sinensis, is umbelliferae angelica（Angelica sinensis）Dry root, sweet, pungent, temperature；Return
Liver, the heart, the spleen channel；Enrich blood；Promoting blood circulation；Menstruction regulating and pain relieving；Moisturize laxation；It is mainly used in all cards of the deficiency of blood；Irregular menstruation；Amenorrhea；Dysmenorrhoea；Disease
Lump in the abdomen knot is poly-；Uterine bleeding；Asthenia cold abdominalgia；Impotence numbness；Numbness；Intestines are dry and shit is difficult；Weight after dysentery characterized by blood in the stool；Ulcer sores；Injury from falling down etc.；
Ligusticum wallichii, is samphire Ligusticum wallichii（Ligusticum chuanxiong Hort.）Rhizome, be usually used in blood-activating and qi-promoting,
Wind-expelling pain-stopping, Ligusticum wallichii pungent-warm perfume (or spice) is dry, walks and does not keep, can go it is scattered, it is up up to mountain peak top；Enter blood system again, it is descending up to the sea of blood, it is living
Blood and dissolving stasis effect is extensive, the various illnesss of suitable stagnation of blood stasis；Wind-expelling pain-stopping, effectiveness is favourable, can control head wind headache, arthralgia due to wind-dampness etc.
Disease；
Pseudo-ginseng, is the dry root and rhizome of panax araliaceae plant Panax notoginseng (Burk.) F.H.Chen；Taste
Sweet, slight bitter, temperature；Return liver, stomach；Dissipate stasis of blood hemostasis, detumescence ding-tong；Spitting of blood is generally used for, is spitted blood, bleeding from five sense organs or subcutaneous tissue is had blood in stool, uterine bleeding, wound
Bleeding, chest and abdomen shouting pain, tumbling and swelling；Pseudo-ginseng is a kind of conventional promoting blood circulation medicine, but, treat closed only with pseudo-ginseng
Muscles and bones joint injury and soft tissue injury, its less effective；
Safflower, is feverfew safflower（Carthamus tinctorius L.）Drying spend entirely, nature and flavor：It is pungent, temperature；The thoughts of returning home, liver
Jing；Invigorate blood circulation, stasis eliminatings pain relieving；It is mainly used in treating Amenorrhea, abdominal mass, difficult labour, stillborn foetus, disease that postpartum lochia can't go, hemostasis are had a pain, carbuncle
It is swollen, injury from falling down；Present inventor adopts safflower, pseudo-ginseng, and their combination, for treating closed muscles and bones joint
Damage and soft tissue injury, its effect is not good enough, and cure rate is less than 10%.
Peach kernel, is rosaceous plant peach Prunus persica (L.) Batsch or mountain peach Prunus davidiana
(Carr.) dry mature seed of Franch., nature and flavor：Bitter, sweet, flat；The thoughts of returning home, liver, large intestine channel；Promoting blood circulation, relaxes bowel,
It is relieving cough and asthma；For Amenorrhea dysmenorrhoea, lump in the abdomen lump in the abdomen lump in the abdomen, lung carbuncle acute appendicitis, injury from falling down, dry constipation of intestines, cough and asthma；The application's sends out
A person of good sense adopts peach kernel, and peach kernel and safflower, at least one combination of pseudo-ginseng, for treat closed muscles and bones joint injury and
Soft tissue injury, its effect is not good enough, and best cure rate is less than 15%；
The bark of eucommia, is the Eucommiaceae plant bark of eucommia（Eucommia ulmoides Oliver）Dry bark, property is sweet, temperature；Return liver, kidney
Jing；For filling liver kidney, spinal column ache, foot and knee flaccidity, dribbling urination, uncontrolled urination, hypertension, antiabortive effect are controlled；
Dried orange peel, is the dry mature skin of rutaceae orange Citrus reticulata Blanco and its variety, taste
It is bitter, pungent, it is warm in nature；Return lung, the spleen channel；Regulating qi-flowing for strengthening spleen is eliminating dampness and eliminating phlegm；Abdominal fullness and distention is generally used for, deficiency of food is vomited and diarrhoea, coughing with a lot of sputum；
Aconiti preparata,radix, is ranunculaceae plant monkshood（Aconitum carmichaelii）The processed product of dry root, taste is pungent, hardship, property
Heat；The thoughts of returning home, liver,kidney,spleen Jing, dispelling wind and eliminating dampness, antalgic is usually used in for wind-cold-dampness arthralgia, and joint crymodynia, cold hernia is had a pain and fiber crops
Liquor-saturated pain relieving；
Wild aconite root, is the ranunculaceae plant north rhizome of Chinese monkshood（Aconitum kusnezoffii Reichb.）The processed product of dried root,
Taste is pungent, hardship, property heat；The thoughts of returning home, liver,kidney,spleen Jing；Dispelling wind and eliminating dampness, antalgic；For wind-cold-dampness arthralgia, arthralgia, Xin Fuling
Bitterly, cold hernia pain relieving.
As preferred technical scheme：It is made up of following components in parts by weight：
Radix Angelicae Sinensis：18-20 parts, Ligusticum wallichii：16-18 parts, pseudo-ginseng：8-10 parts, safflower：8-10 parts, peach kernel：8-10 parts, the bark of eucommia：8-10
Part, dried orange peel：8-10 parts, aconiti preparata,radix：8-9 parts, wild aconite root：8-9 parts.
Its is better.
As further preferred technical scheme, it is made up of following components in parts by weight
Radix Angelicae Sinensis：20 parts, Ligusticum wallichii：16 parts, pseudo-ginseng：10 parts, safflower：9 parts, peach kernel：9 parts, the bark of eucommia：9 parts, dried orange peel：9 parts, aconiti preparata,radix：
8 parts, wild aconite root：8 parts.
Its effect can reach most preferably.
The second object of the present invention is to provide pharmaceutical preparation made by a kind of above-mentioned pharmaceutical composition.
It is preferred that described pharmaceutical preparation is powder, it is of course also possible to paste, tincture or other external preparations.
The preparation method of the powder is：Weigh in the ratio, be then comminuted into fine powder, sieve, mix, obtain final product.Most
After obtain yellowish-brown to filemot powder；Gas is fragrant.Preparation method is simple.
As preferred technical scheme：120 mesh sieves are crossed after crushing.Suitable granularity, more conducively medicine plays a role.
In sum, as a result of above-mentioned technical proposal, the invention has the beneficial effects as follows：The present invention is for various closures
Property soft tissue injury can quick swelling and pain relieving, promote the fast quick-recovery normal function of soft tissue, for acute bruise, muscle
Pull, articular ligament is pulled it is efficient up to 100%, cure rate is up to 99%, and short treating period, can disappear substantially in general 24 hours
It is swollen, can recover completely in one week；And for chronic tenosynovitis, scapulohumeral periarthritis etc., efficient up to 100%, cure rate is up to 95%
More than, determined curative effect, toxic and side effect are little, with low cost, can significantly mitigate financial burden and the mental burden of patient.
Specific embodiment
Below the present invention is described in detail.
In order that the objects, technical solutions and advantages of the present invention become more apparent, with reference to embodiments, to the present invention
It is further elaborated.It should be appreciated that specific embodiment described herein is not used to only to explain the present invention
Limit the present invention.
Embodiment 1：
A kind of powder for treating soft tissue injury, is made up of following components in parts by weight：
Radix Angelicae Sinensis：16 parts, Ligusticum wallichii：18 parts, pseudo-ginseng：7 parts, safflower：7 parts, peach kernel：7 parts, the bark of eucommia：7 parts, dried orange peel：7 parts, aconiti preparata,radix：7
Part, wild aconite root：7 parts；
Preparation method is：Weigh in the ratio, be then comminuted into fine powder, cross 120 mesh sieves, mix, obtain final product.
Embodiment 2
A kind of powder for treating soft tissue injury, is made up of following components in parts by weight：
Radix Angelicae Sinensis：18 parts, Ligusticum wallichii：20 parts, pseudo-ginseng：9 parts, safflower：9 parts, peach kernel：11 parts, the bark of eucommia：11 parts, dried orange peel：11 parts, system
Monkshood：10 parts, wild aconite root：10 parts；
Preparation method is：Weigh in the ratio, be then comminuted into fine powder, cross 120 mesh sieves, mix, obtain final product.
Embodiment 3
A kind of powder for treating soft tissue injury, is made up of following components in parts by weight：
Radix Angelicae Sinensis：20 parts, Ligusticum wallichii：16 parts, pseudo-ginseng：10 parts, safflower：9 parts, peach kernel：9 parts, the bark of eucommia：9 parts, dried orange peel：9 parts, aconiti preparata,radix：
8 parts, wild aconite root：8 parts；
Preparation method is：Preparation method is：Weigh in the ratio, be then comminuted into fine powder, cross 120 mesh sieves, mix, obtain final product.
Embodiment 4
For motility bruise, pulled muscle, articular ligament Treatment clinical testing
4.1 case selection standard：
Definition：Due to reasons such as strenuous exercise or prudent improper, bruise, drawing and excessive torsions, tendon and vessel and joint is caused to damage
Wound, Jing fate rows are obstructed, stagnation of QI-blood local forms, and cause the soft tissue of four limbs or body part such as skin, muscle, tendon, tough
Band, blood vessel equivalent damage, and without the damaged damage disease of fracture, dislocation, skin and flesh, clinical signs are injury swelling pain,
Joint movement disorder etc.；
4.2 case scenario
Motility bruise, pulled muscle, the joint of all ages and classes, different sexes, the different state of an illness are chosen by 4.1 definition standard
Ligament injury patient 300,
Wherein, 15-30 year 100,31-45 year 100,46-60 year 100；The male sex 200, women 100；
4.3 treatment method
After generation soft tissue injury, treat in time, treatment method is：According to affected part size, dissipating obtained by Example 3
Appropriate agent, first adds white wine, rear warm water that medical powder is adjusted into pasty state, affected part is spread on；Used once every 12 hours, according to
The difference of conditions of patients, continuous application 2-10 days.
4.4 the standard of curative effect evaluation
Evaluated according to following standards：
Cure：Affected part redness is wholly absent, and pain is wholly absent, and freely, physico-chemical examination is completely normal for limb activity, after 6 months
Follow-up is without any repeatedly or uncomfortable；
It is effective：The red and swollen basic disappearance in affected part, pain disappears substantially, and limb activity is substantially freely；
Effectively：Affected part is red and swollen substantially to mitigate, and pain substantially mitigates；
It is invalid：Compared with pre-treatment, red and swollen, pain is without change.
4.5 treatment results
Above-mentioned 300 cases, cure：298；It is effective：1；Effectively:1；It is invalid：0, efficient is 100%, and cure rate is
99.3%, motility bruise, pulled muscle, articular ligament are pulled；And all patients are not fed back including including allergic
Any bad reaction；
In addition, cure follow-up after half a year, and in 298 of healing, the case without any one recurrence or sequelae.
Embodiment 5
Model case in the case of embodiment 4 is enumerated：
Man, 55 years old, because tumble injury, causes left leg swollen very severe, its 5cm thicker than the footpath of normal right leg；Subcutaneous have a hemostasis, non-
Normal pain, the powder obtained by application embodiment 3, red and swollen after 2 days substantially to disappear, pain substantially mitigates, red and swollen complete after 5 days
Disappear, pain disappears substantially, can normally walk after 10 days, shank function recovers completely normal, follow-up after 6 months, nothing is appointed
What is repeatedly or sequelae.
Female, 16 years old, the careless lateral ligament of ankle joint of physical education was pulled, and pulled position swelling and hemostasis, hurt like hell, substantially
Can not normally walk, the powder obtained by application embodiment 3, red and swollen after 1 day substantially to disappear, pain substantially mitigates, red after 3 days
Swollen to be wholly absent, pain disappears substantially, can normally walk after 6 days, follow-up after 6 months, without it is any repeatedly or sequelae.
Embodiment 6
For tenosynovitis, the clinical testing of scapulohumeral periarthritis
6.1 case selection
The patient 100 of tenosynovitis is diagnosed as in certain Hospital choice, the patient 100 of scapulohumeral periarthritis is diagnosed as；
Wherein, the male sex 120, women 80；Divide from the age, 30-50 year 100,51-65 year 100,6.2 treatment sides
Method
The powder of the gained of the application embodiment of the present invention 3, one time a day, according to the difference of the state of an illness, continuous use 15-60 days；
6.3rd, efficacy assessment standard
Cure:For tenosynovitis, swelling is wholly absent, and freely, function recovers completely normal to the activity of finger wrist；For shoulder
For Zhou Yan, shoulder arthralgia is wholly absent, and completely freely, physico-chemical examination prepares completely normal for activity；
It is effective：For tenosynovitis, swelling is obviously improved, and finger wrist activity is obviously improved, and function is returned to normal；It is right
For scapulohumeral periarthritis, shoulder arthralgia substantially mitigates, and activity is substantially freely；
Effectively：For tenosynovitis, swelling improves, finger wrist improving action, and funtion part recovers normal；For scapulohumeral periarthritis
For, shoulder arthralgia mitigates；
It is invalid：Compare with before medication, without any change.
6.4 treatment results
Cure：191
Effectively：9
It can be seen that, for chronic soft tissue injuries such as tenosynovitis and scapulohumeral periarthritis, the present invention's is efficient up to 100%, and cure rate is reachable
95%.In addition, for 191 cured, paying a return visit after half a year, only 9 recurrences, recurrence rate is very low.
Claims (7)
1. a kind of pharmaceutical composition for treating soft tissue injury, it is characterised in that be made up of following components in parts by weight：
Radix Angelicae Sinensis：16-20 parts, Ligusticum wallichii：16-20 parts, pseudo-ginseng：7-11 parts, safflower：7-11 parts, peach kernel：7-11 parts, the bark of eucommia：7-11
Part, dried orange peel：7-11 parts, aconiti preparata,radix：7-10 parts, wild aconite root：7-10 parts.
2. the pharmaceutical composition for treating soft tissue injury according to claim 1, it is characterised in that by following weight
The component composition of part：
Radix Angelicae Sinensis：18-20 parts, Ligusticum wallichii：16-18 parts, pseudo-ginseng：8-10 parts, safflower：8-10 parts, peach kernel：8-10 parts, the bark of eucommia：8-10
Part, dried orange peel：8-10 parts, aconiti preparata,radix：8-9 parts, wild aconite root：8-9 parts.
3. the pharmaceutical composition for treating soft tissue injury according to claim 2, it is characterised in that by following weight
The component composition of part：
Radix Angelicae Sinensis：20 parts, Ligusticum wallichii：16 parts, pseudo-ginseng：10 parts, safflower：9 parts, peach kernel：9 parts, the bark of eucommia：9 parts, dried orange peel：9 parts, aconiti preparata,radix：
8 parts, wild aconite root：8 parts.
4. pharmaceutical preparation made by the composition of claim 1-3 any one is adopted.
5. pharmaceutical preparation according to claim 4, it is characterised in that：The preparation is powder.
6. the preparation method of powder described in claim 5, it is characterised in that：Weigh in the ratio, be then comminuted into fine powder, mistake
Sieve, mixes, and obtains final product.
7. preparation method according to claim 6, it is characterised in that：120 mesh sieves are crossed after crushing.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611189326.9A CN106581235A (en) | 2016-12-21 | 2016-12-21 | Pharmaceutical composition for treatment of soft tissue injuries |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611189326.9A CN106581235A (en) | 2016-12-21 | 2016-12-21 | Pharmaceutical composition for treatment of soft tissue injuries |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106581235A true CN106581235A (en) | 2017-04-26 |
Family
ID=58600009
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201611189326.9A Pending CN106581235A (en) | 2016-12-21 | 2016-12-21 | Pharmaceutical composition for treatment of soft tissue injuries |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106581235A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107260828A (en) * | 2017-05-23 | 2017-10-20 | 四川何天祺医院管理有限公司 | Pharmaceutical composition for treating closed soft tissue injury and injured bones and muscles |
| CN108837038A (en) * | 2018-08-14 | 2018-11-20 | 耿马汇裕康药材生物科技有限责任公司 | A kind of Chinese medicinal composition for treating tendon injury |
| CN110339245A (en) * | 2019-08-23 | 2019-10-18 | 云南善润经贸有限公司 | A kind of Chinese medicine therapy liquid and preparation method thereof |
| CN113144018A (en) * | 2021-04-07 | 2021-07-23 | 重庆三峡医药高等专科学校 | Traditional Chinese medicine composition for treating blunt injury of soft tissues and extract and application thereof |
| CN115429844A (en) * | 2022-09-15 | 2022-12-06 | 简正立 | Medicinal liquor for treating arthralgia |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101322828A (en) * | 2008-08-06 | 2008-12-17 | 郑昆仑 | Medicament for treating soft tissue scathing |
| CN103169830A (en) * | 2013-04-09 | 2013-06-26 | 肖才安 | External medicinal liquor for treating closed soft tissue injury |
-
2016
- 2016-12-21 CN CN201611189326.9A patent/CN106581235A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101322828A (en) * | 2008-08-06 | 2008-12-17 | 郑昆仑 | Medicament for treating soft tissue scathing |
| CN103169830A (en) * | 2013-04-09 | 2013-06-26 | 肖才安 | External medicinal liquor for treating closed soft tissue injury |
Non-Patent Citations (2)
| Title |
|---|
| 崔伟等: "外治验方在软组织损伤疾病的临床应用", 《中医外治杂志》 * |
| 王志勇等: "中医外治法治疗急性软组织损伤研究概况", 《甘肃中医学院学报》 * |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107260828A (en) * | 2017-05-23 | 2017-10-20 | 四川何天祺医院管理有限公司 | Pharmaceutical composition for treating closed soft tissue injury and injured bones and muscles |
| CN108837038A (en) * | 2018-08-14 | 2018-11-20 | 耿马汇裕康药材生物科技有限责任公司 | A kind of Chinese medicinal composition for treating tendon injury |
| CN110339245A (en) * | 2019-08-23 | 2019-10-18 | 云南善润经贸有限公司 | A kind of Chinese medicine therapy liquid and preparation method thereof |
| CN113144018A (en) * | 2021-04-07 | 2021-07-23 | 重庆三峡医药高等专科学校 | Traditional Chinese medicine composition for treating blunt injury of soft tissues and extract and application thereof |
| CN113144018B (en) * | 2021-04-07 | 2022-03-25 | 重庆三峡医药高等专科学校 | Traditional Chinese medicine composition for treating blunt injury of soft tissues and extract and application thereof |
| CN115429844A (en) * | 2022-09-15 | 2022-12-06 | 简正立 | Medicinal liquor for treating arthralgia |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106581235A (en) | Pharmaceutical composition for treatment of soft tissue injuries | |
| CN100998799A (en) | Chinese medicinal preparation for treating fracture, traumatic injury | |
| CN104771654B (en) | Treat Chinese medicine of lumbar vertebrae, cervical vertebrae hyperosteogeny and preparation method thereof | |
| CN102908442B (en) | Composition for treating traumatic injuries and medicinal liquor thereof | |
| CN106728958A (en) | Pharmaceutical composition for treating muscles and bones arthralgia | |
| CN105920570A (en) | Quick-acting externally applied traditional Chinese medicine for treating rheumatoid bone diseases and preparation method | |
| CN108272947A (en) | A kind of blood-activating analgesic plaster and preparation method thereof | |
| CN106729429A (en) | A kind of Chinese medicine composition promoting blood circulation and removing blood stasis and preparation method thereof | |
| CN105664053A (en) | Traditional Chinese medicine composition for treating calluses on puncture of internal arteriovenous fistula of maintenance hemodialysis patient | |
| CN106511630B (en) | A kind of external used medicine for treating rheumatic arthritis and preparation method thereof | |
| CN107213347A (en) | It is a kind of to treat orthopaedics bone-set plaster of fracture and preparation method thereof | |
| CN106310172A (en) | Ointment medicine for treating painful diseases and preparing method and use thereof | |
| CN104352843A (en) | Tendon-relaxing and collateral-activating preparation for bone injury prognosis and preparation method of tendon-relaxing and collateral-activating preparation | |
| CN104257995A (en) | External application patch for treating traumatic injuries and preparation method thereof | |
| CN105232642A (en) | Traditional Chinese medicine combination capable of promoting fracture healing | |
| CN105012747A (en) | Bone-setting ointment for treating fractures and preparation method thereof | |
| CN104800804A (en) | Medicament for quickly and efficiently treating fracture and preparation method of medicament | |
| CN117357608A (en) | External application medicine for treating traumatic injury and fracture and tendon injury | |
| CN102824582B (en) | Method of preparing traditional Chinese medicine lotion for treating dystrophic type closed fracture | |
| CN109620919A (en) | A kind of Chinese materia medica preparation and preparation method thereof for treating osteopathy | |
| CN103798720A (en) | Eucommia bark hot-pot flavoring capable of strengthening muscles and bones and production method thereof | |
| CN114028473A (en) | A Chinese medicated liquor for treating traumatic injury, and its preparation method | |
| CN103735676A (en) | Traditional Chinese medicine compound preparation for treating traumatic injury, and preparation method and application thereof | |
| CN115554227A (en) | Medicinal liquor for treating traumatic injury | |
| CN103861062A (en) | Traditional Chinese medicine composition for treating rheumatoid diseases and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170426 |